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Purpose: In patients with intermittent claudication (IC) a structured walking exercise 
program improves exercise performance. However, few studies have evaluated the effects 
of exercise training on fianctional status during daily activities. We hypothesized that a 
supervised exercise training program would improve functional status in patients with IC, 
with 24 weeks of training more beneficial than 12 weeks. A secondary aim was to evaluate 
the effects of strength training and combinations of strength and treadmill training on 
fimctional status. 
Methods: Twenty-nine men with disabling IC were randomized to 12 weeks of either 
supervised treadmill training (3 hr/wk at a work intensity sufficient to produce 
claudication), strength training (3 hr/wk of resistive training of six muscle groups of each 
leg), or to a nonexercising control group. Functional status was assessed by questionnaires 
characterizing walking ability (Walking Impairment Questionnaire, WIQ), habitual 
physical activity level (Physical Activity Recall, PAR), and physical, social, and role 
functioning, well-being, and overall health (Medical Outcomes Study SF-20, MOS). 
Patients also had their activity levels monitored with an activity monitor (Vitalog). 
Results: After 12 weeks of treadmill training PAR scores increased by 48 metabolic 
equivalent hr/wk, the MOS physical functioning score by 24 percentage points, and the 
number of bouts of walking activity measured by the Vitalog by 4.5 bouts/hr (all 
p < 0.05). No changes were seen in WIQ scores. After 12 additional weeks of treadmill 
training improvements initially observed in the PAR, MOS, and Vitalog scores were 
maintained, and in addition the ability to walk distances (WIQ) improved by 31 percentage 
points, and the IC severity score had improved by 29 percentage points (bothp < 0.05). 
After 12 weeks of stt'ength training patients improved their WIQ walking speed, stair 
climbing scores, and MOS well-being scores with no other changes in functional status. 
Subjects in the control group did not improve functional status by any measure. Twelve 
weeks of treadmill training after the strength training program maintained WIQ walking 
speed scores, and activity level defined by Vitalog improved. Twelve weeks of combined 
treadmill and strength training after the control period had no effect on functional status. 
Conclusions: A supervised treadmill training program improved functional status during 
daily activities, with 24 weeks more effective than 12. In addition, treadmill training alone 
was more effective in improving functional status in patients with IC than strength 
training or combinations of the training modalities. (J VASC SURG 1996;23:104-15.) 
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Patients with intermittent claudication have a 
moderate to severe impairment of walking ability that 
may limit their ability to meet the personal, social, 
or occupational demands of  daily living. In patients 
with claudication a supervised walking exercise pro- 
gram improved walking ability as measured by 
pain-free and maximal walking distance with tread- 
mill testing. 1-3 However, the treadmill test does not 
measure the effects of an intervention on the patient's 
perceived ability to walk or carry out activities in 
the community (nonlaboratory) setting. Therefore 
changes in treadmill performance do not completely 
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characterize the patient's functional response to an 
exercise training program. 
Questionnaires and activity monitors that evalu- 
ate functional status may play an important role in 
describing the benefits of interventions in patients 
with peripheral arterial disease (PAD). One such 
instrument is the Walking Impairment Question- 
naire (WIQ), which has been developed and vali- 
dated to quantify the ability to walk defined istances, 
speeds, and stairs and to characterize the symptoms 
that limit walking ability in patients with PAD .4 The 
WIQ has previously been used in the PAD popula- 
tion to evaluate changes in walking ability with 
exercise training, 3'4 peripheral bypass, 6 and angio- 
plasty. 6The Physical Activity Recall (PAR) provides 
a more general measure of physical activity by 
assessing the total energy expenditure of the patient 
at work and during home and leisure-time activities 
for the preceding week. 7 The PAR has primarily been 
used in large population studies to evaluate habitual 
physical activity levels in healthy persons and in 
persons with diabetes. 7~~ The Medical Outcomes 
Study questionnaire (MOS SF-20) evaluates physi- 
cal, social, and role functioning and patients' percep- 
tion of their general health and well-being. H,12 This 
questionnaire has been used in population studies to 
evaluate functional status in a number of disease 
states and in healthy persons. 11,~2 Finally, a variety of 
devices have been developed that directly measure 
activity level. The Vitalog activity monitor (Vitalog 
Corporation, Mountain View, Calif.) measures ac- 
tivity and heart rate with a motion sensor and 
electrocardiographic (EKG) monitoring and has 
been used to evaluate changes in activity levels in 
healthy sedentary individuals before and after exercise 
training.IS,14 
In addition to questions about the effects of 
treadmill training on functional ability, the effects of 
other modes of exercise training on functional status 
in the PAD patient population have not been fully 
assessed. In our study strength training of the lower 
leg muscles was evaluated because of the observation 
that patients with PAD have leg muscle weakness, i  
In addition, it has previously been observed that 
strength training may augment he response to an 
aerobic training program in normal subjects. 16 
Our study was designed to test the hypothesis 
that a treadmill training program would improve 
functional status during daily activities in patients 
with disabling claudication, with 24 weeks more 
beneficial than 12 weeks. A secondary aim was to 
investigate the effects of strength training or combi- 
nations of strength and treadmill training on improv- 
ing functional status. Questionnaires and an activity 
monitor were administered to patients with claudi- 
cation on entry to and after 12 and 24 weeks of a 
randomized controlled trial of exercise conditioning. 
METHODS 
Subjects. Forty-four people were evaluated for 
the study. All patients had disabling intermittent 
claudication, defined as of a severity sufficient o 
interfere with the ability of the patient o perform 
social, recreational, or vocational activities. Claudi- 
cation was the limiting symptom during daily activi- 
ties and during treadmill exercise in the laboratory. 
Claudication symptoms were stable over a 3-month 
period before nrollment (change less than one block 
in walking distance by history). Peripheral arterial 
disease was confirmed by an ankle/arm systolic blood 
pressure ratio of less than 0.94 at rest that decreased 
to less than 0.73 after exercise. 17 The study was 
approved by the University of Colorado School of 
Medicine Human Subjects Committee, and in- 
formed consent was obtained from all enrolled 
subjects. 
Of the 44 patients evaluated 15 were excluded 
before randomization, and 29 of the original 44 
patients were subsequently enrolled and randomized 
into the study. Patients were excluded from study if 
they had ischemic rest pain, ischemic ulceration, or 
gangrene. Patients were also excluded if they were 
unable to walk on the treadmill at a speed of at least 
2 mph, or if exercise capacity was limited by 
symptoms of angina, congestive heart failure, chronic 
obstructive pulmonary disease, or arthritis. Diabetics 
were excluded because the degree of glycemic ontrol 
may affect he response to a conditioning program; 
patients with poor glycemic ontrol may not improve 
their conditioning status.18 In addition, we wished to 
avoid the confounding effect possibly resulting from 
complications common to diabetes (i.e., neuropathy, 
autonomic dysfunction) that can interfere with the 
ability to benefit from a training program. Patients 
who had undergone a vascular surgical procedure or 
angioplasty within the previous year were also 
excluded from the study. Patients taking chronic 
medications were continued on their drugs, with the 
dosage unchanged uring the study.' Of the 29 
patients who participated in the'trial, one in the 
treadmill and strength-trained groups each was on a 
13-blocker, and two in the control group were on a 
13-blocker. Three patients in each group were taking 
pentoxifylline. 
Design. After a series of initial evaluation 
procedures were performed, the 29 eligible patients 
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were randomized into one of three groups (Table I). 
Treated subjects were enrolled in either a 12-week 
program of supervised treadmill walking exercise 
(n = 10) or strength training (n = 9). Subjects in 
the control group (n = 10) were instructed not to 
change their usual level of activity. Two subjects in 
the control group did not return for the 12-week 
evaluation, so that although they were included in the 
initial description of the study population, they were 
excluded from further analysis. After the first 12 
weeks the effects of the two types of treatment were 
compared with each other and with the nontreatment 
control group. 
In the second phase of the study patients in the 
treadmill group continued for an additional 12 weeks 
of treadmill training to determine whether a total of 
24 weeks of training produced greater improvements 
in functional status than 12 weeks alone. One subject 
refused to continue in the second phase, leaving nine 
subjects completing the full 24 weeks. 
Subjects initially randomized to strength training 
entered into a treadmill training program in the 
second 12 weeks to determine whether an initial 
period of muscle strengthening would accentuate he 
functional benefits of treadmill exercise. Three sub- 
jects refused to participate, leaving six randomized 
subjects completing the full 24-week program. Six 
subjects in the control group (two declined to 
participate) ntered acombined program of strength- 
ening and treadmill walking exercise for the second 
12 weeks of the study. 
Treadmill testing. Subjects were tested on a 
graded treadmill protocol on entry and after 12 and 
24 weeks. After a familiarization treadmill test was 
performed uring the initial visit, a second test on 
another day was used for data analysis. Subjects 
walked on the treadmill at an initial workload of 2 
mph, 0% grade for 3 minutes. Subsequent stages 
increased 3.5% in grade every 3 minutes (with no 
change in speed) to maximal claudication pain as 
previously described. 3a9 During exercise, heart rate 
(by 12-lead EKG) and arm blood pressure were 
monitored every minute. The change in the severity 
of claudication pain experienced by the patient was 
recorded on a scale of 1 to 5 with 1 = no pain, 
2 = onset claudication, 3 = mild, 4 = moderate, 
and 5 -- severe pain. All subjects reached amaximal 
level of claudication pain that limited exercise during 
the graded treadmill test. 
Assessment of functional status. A trained 
research assistant administered all questionnaires on 
entry to the study and after 12 and 24 weeks. The 
PAD WIQ has been validated by comparison with 
treadmill walking in the PAD population. 4,s With 
this instrument he patient assessed his perceived 
difficulty in walking defined istances and speeds, the 
ability to climb stairs, and the degree of impairment 
caused by the symptoms of claudication. Responses 
to individual items within a category were ranked on 
a scale of 0 to 3, (0 = did not do, 3 = no difficulty) 
and were aggregated within the category into a single 
summary score as previously described. 4 The distance 
summary score ranged from 0% (patient unable to 
walk 50 feet without claudication pain) to 100% 
(patient able to walk five blocks without clandication 
pain). The summary score for walking speed ranged 
from 0% (patient unable to walk one block slowly 
without claudication pain) to 100% (patient able to 
jog one block without difficulty). The stair climbing 
score was rated so that 0% meant a patient could not 
climb one flight of stairs without claudication, while 
100% meant no difficulty in climbing three flights of 
stairs. The claudication severity score was scaled so 
that 0% indicated that the patient had much claudi- 
cation pain when walking, while 100% indicated no 
claudication with walking. 
The Physical Activity Recall (PAR), a measure of 
habitual physical activity, was used to evaluate nergy 
expenditure for all awake hours of the previous 
week7 The PAR was chosen because of previous use 
and validation in other studies. 7q~ Reliability was 
established for the PAR in the Five-City Project (a 
population study) with test-retest measures at ali 
study sites. 7The PAR has also been used to evaluate 
the effects of increased physical activity on treadmill 
and questionnaire responses) ~ Changes in PAR 
scores correlated with increased caloric expenditure 
as assessed by an activity monitor. 9
The PAR assesses all types of physical activity 
(occupational, leisure, and home). The amount of 
energy expenditure for each activity was quantified in 
terms of metabolic equivalents (1 MET equals 3.5 
ml/kg/min of oxygen consumption) per activity. 
Participants were asked about the number of hours 
spent performing very light (1.0 to 1.5 METs), light 
(2 to 3 METs), moderate (3 to 5 METs), heavy (5 to 
7 METs), and very heavy (7+ METs) activities. 7
Data are reported in MET hr/week, derived by 
multiplying the amount of time spent performing an 
activity by the MET value of the activity. 
The Medical Outcomes Study (SF-20) instru- 
ment, which has been validated and found to be 
reliable in large populations of healthy and diseased 
individuals, was used to measure physical, social, and 
role functioning, well-being, and overall health. 1~'12 
Each of the five domains measured was scored 
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Table I. Study design, treadmill exercise performance, and hemodynamics 
Entry 12 Weeks 24 Weeks 
Treadmill Treadmill 
No. 10 10 9 
Peak treadmill 
Walking time (min) 9.6 -+ 5.7 14.7 + 7.3* 17.2 -+ 7.3"1 
Ankle/brachial index 
Rest 0.55 -+ 0.15 0.53 + 0.16 0.53 + 0,18 
After exercise 0.21 _+ 0.11 0.16 -+ 0.15 0.14 +_ 0.12 
Strength Treadmill 
No. 9 9 6 
Peak treadmill 
Walking time (min) 6.5 +- 2.9 8.5 -+ 5.2* 11.8 +- 6.0*t 
Ankle/brachial index 
Rest 0.52 -+ 0.27 0.45 + 0.32 0.45 - 0.33 
After exercise 0.23 -+ 0.25 0.21 +_ 0.22 0.29 -+ 0.32 
Control Treadmill + Strength 
No. 10 8 6 
Peak treadmill 
Walking time (min) 7.4 _+ 3.3 7.3 -+ 2.7 13.2 _+ 6.6"t  
Ankle/brachial index 
Rest 0.61 + 0.15 0.61 -+ 0.18 0.59 -+ 0.19 
After exercise 0.29 -+ 0.10 0.29 +- 0.12 0.22 + 0.21 
Results are mean -+ SD. 
*p < 0.05 week 12 or 24 versus entry value. 
tp < 0.05 for the 24-week versus 12-week value. 
separately on a scale of 0% to 100%. A typical range 
of responses for many diseases, although not PAD, 
has been established for this questionnaire, x2 
To minimize the potential for bias in the self- 
evaluation of walking ability and functional status, 
the questionnaires were administered before the 
treadmill test. Thus patients' questionnaire r sponses 
were not influenced by their treadmill exercise 
performance. In addition, the interviewer and patient 
were blinded to previous questionnaire scores. 
Activity monitor. To obtain a more objective 
assessment of changes in activity with training, 
subjects were evaluated with the Vitalog activity 
monitor.13 The Vitalog microcomputer was worn by 
a subset of Batients in each group for a 1-day period, 
but not on a training day. In the first 12 weeks eight 
treadmill-trained, six strength-trained, and six pa- 
tients in the control group were monitored. In the 
second 12 weeks seven subjects who continued on 
with treadmill training, three who received treadmill 
training after strength training, and five who received 
the combined training program were monitored. 
The Vitalog continuously measures heart rate by 
EKG and activity with a group of mercury switches 
placed on the upper thigh. The Vitalog was individu- 
ally calibrated for each patient during the entry 
maximal treadmill test. Each patient's threshold for 
activity was the heart rate by EKG and the number of 
counts registered by the motion sensor when the 
patient was walking on the treadmill at 2 mph, 0% 
grade. Data were analyzed as the number and 
duration of bouts of activity (defined as any period of 
activity above the individual threshold). Values are 
also expressed as the number of minutes active per 
hour and the percent of time active during the course 
of the monitored session. 
Training programs. All training programs 
began with 5 minutes of warm-up and ended with 5 
minutes of cooldown. Subjects randomized to the 
treadmill training program were trained as previously 
described, 1 hr/day three times per week? 
Supervised strength training was conducted 1
hr/day three times per week by a physical therapist. 
Subjects performed resistive, isotonic 'training of 
muscle groups in each leg (anterior tibialis, 
gastrocnemius-soleus, hamstrings, quadriceps femo- 
ris, gluteus medius, and gluteus maximus). The 
training program consisted of applying aresistance to " 
each muscle group with a cuff weight secured to the 
appropriate part of the leg. On entry, the weight hat 
caused fatigue in the muscle group after six contrac- 
tions (maximum intensity repetitions, or six- 
repetition maximum) was established. Every 2 weeks 
the six-repetition maximum was reassessed, and the 
weights were changed accordingly. Exercise training 
consisted of the subjects performing six contractions 
of the six muscle groups in a given leg, followed by 
a rest period, and then repeating this circuit for a total 
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of three sets per session. No treadmill walking was 
performed by this group. 
Patients in the combined strength and treadmill 
walking exercise program participated in three 90- 
minute sessions per week. Treadmill training was 
conducted for 60 minutes, followed by 30 minutes 
of strength training of the anterior tibialis, 
gastrocnemius-soleus, andgluteus maximus muscles 
of each leg. 
Data analysis. Differences among the three 
groups on entry were determined with a between- 
subjects analysis of variance. Changes in exercise 
performance and ankle-brachial indexes after 12 and 
24 weeks of training were assessed by a within- 
subjects analysis of variance. Given the potential for 
variability in questionnaire responses and Vitalog 
assessments, the changes in these measures from 
baseline are expressed as the mean change and the 
95% confidence interval of the change. This analysis 
allows the reader to better assess the range in 
responses for each measure. Correlations were calcu- 
lated with the Pearson product-moment correlation 
coefficient. Values are reported as mean + SD and 
considered significant whenp < 0.05 in a two-tailed 
test. 
RESULTS 
On entry, subjects were well matched by age 
(average age was 67 years in all three groups). 
According to the WIQ 3 persons were 1/2-block 
clandicators, 5 were one-block claudicators, 12 were 
two-block claudicators, 6 were three-block claudica- 
tors, and 3 were five-block claudicators. None of the 
patients could walk further than five blocks. Patients 
randomized to strength training reported fewer years 
ofclaudication (2 + 1) than did patients in the other 
two groups (4 + 2 for treadmill-trained group and 
4 + 3 for control group) but were similar with 
respect to the frequency of cardiovascular comorbid- 
ity, smoking history, and medication use as previ- 
ously reported. 2~ Patients did not change their 
medication use or smoking status during the course 
of the study. In addition, no differences were seen 
among groups in terms of peak treadmill walking 
time or resting ankle-brachial indices (Table I). After 
exercise was performed, ankle-brachial indices de- 
creased in all three groups. This hemodynamic 
response to exercise was not affected by any of the 
treatment programs. 
Changes in treadmill exercise performance. 
Patients in the treadmill training program increased 
their peak walking time by 74% _+ 58% after 12 
weeks of training (Table I). Twelve additional weeks 
of treadmill training in this group resulted in a further 
increase in peak walking time of 49% _+ 53%. 
Patients in the strength training program had an 
increase in peak walking time of 30% + 48% after 12 
weeks, but the change in peak walking time in this 
group tended to be less than that in the treadmill- 
trained group (p = 0.07). The additional 12 weeks 
of treadmill training in patients who completed 
strength training resulted in an increased peak 
treadmill walking time as compared with values 
obtained after the first 12 weeks by 54% _+ 25% 
(p < 0.05) (Table I). Subjects in the control group 
had no change in peak walking time after 12 weeks; 
those who subsequently entered a combination of 
strength and treadmill training increased their peak 
treadmill walking time as compared with values after 
the 12 weeks of the control period by 99% + 84%, 
(p < 0.05, Table I). These results have been previ- 
ously reported. 2~ 
Changes in questionnaire scores with training. 
After 12 weeks of treadmill training no changes were 
seen in WIQ scores (Table II). However, 12 addi- 
tional weeks of treadmill training (total of 24 weeks) 
was associated with an increase in the WIQ distance 
score of 31 percentage points and the claudication 
pain severity score of 29 percentage points (both 
p < 0.05). Walking speed and stair climbing scores 
tended to increase as well (p < 0.10). After 12 weeks 
of strength training the ability to climb stairs as 
measured by the WIQ improved 22 percentage 
points, and walking speed increased 16 percentage 
points (both p < 0.05), with no changes in other 
WIQ scores. The addition of treadmill training after 
strength training was associated with a maintained 
improvement in walking speed, but stair climbing 
ability was no longer increased over entry values. No 
improvements in WIQ scores were found for the 
control group after 12 weeks. The combined pro- 
gram of treadmill and strength training after the 
control period did not produce .any improvement in
the WIQ scores. 
The PAR scores in the treadmill-trained group 
improved by 48 MET hr/wk (p < 0.05) after 12 
weeks of training (Table III). After a total of 24 
weeks of treadmill training PAR scores remained 
elevated over baseline values. No changes in the PAR 
scores were observed in either the strength-trained or 
control groups after 12 weeks. In addition, no 
changes in PAR scores were found in the subjects 
who received treadmill training after strength train- 
ing or in the combined training group. 
In the treadmill-trained group the MOS physical 
functioning scores improved by 24 percentage points 
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Table II. Walking Impairment Questionnaire scores on entry and change from baseline after 12 
and 24 weeks of exercise training 
Entry A Week 12 A Week 24 
Distance score (%) 
TM 48 -+ 30 +8 ( -9  to 26) TM +31 (4 to 57)* 
S 36 +- 26 +6 ( -5 to  18) TM +6 ( -12  to23) 
C 31 -+ 24 +14 ( -10  to 37) TM + S +12 ( -5  to 30) 
Speed score (%) 
TM 32 + 19 +11 ( -11  to 34) TM +14 ( - l to28)  
S 25 + 14 +16 (2 to 30)* TM +9 (3 to 16)* 
C 44 + 29 +15 ( -10to39)  TM+ S +2 ( -24to29)  
Stair score (%) 
TM 44 -+ 35 -7  ( -25  to 11) TM +13 ( -3  to 28) 
S 23 + 20 +22 (4 to 41)* TM + 13 ( -15  to 41) 
C 42 + 27 +11 ( -4 to26)  TM + S -1  ( -18to17)  
Claudication severity (%) 
TM 32 -+ 24 + 12 ( -7  to 30) TM +29 (6 to 53)* 
S 42_+ 31 +6 ( -13tp24)  TM +17 ( -19to53)  
C 31 _+ 29 +22 ( -2  to45)  TM + S +13 ( -24  to 49) 
7718, Treadmill-trained; S, strength-trained; C, control; TM + S, combined treadmill and strength training program. 
Data in parentheses under the week 12 and 24 columns represent 95% confidence intervals of these changes. Results are mean _+ SD. 
A Week 12 and 24 refers to change from baseline at each respective time point. 
~p < 0.05 week 12 or 24 versus entry value. 
Table II I .  Physical Activity Recall scores on entry and change from baseline after 12 and 24 weeks 
of exercise training 
Entry. A Week 12 A Week 24 
MET hours/week 
TM 155 -+ 31 +48 (6 to 94) ~ TM +39 (10 to 67)* 
S 188 _+ 157 -7  ( -57to42)  TM 39 ( -107to  29) 
C 155 + 34 -9  ( -31  to 12) TM + S +6 ( -24  to 36) 
TM, Treadmill-trained; S, strength-trained; C, control; TM + S, combined treadmill and strength training program. 
Data in parentheses under the week 12 and 24 columns represent 95% confidence intervals of these changes. Results are mean + SD. 
A Week 12 and 24 refers to change from baseline at each respective time point. 
~p < 0.05 week 12 or 24 versus entry value. 
after 12 weeks and remained increased after 24 weeks 
of training (p < 0.05, Table IV). No changes were 
seen in the other MOS domains (social, role func- 
tioning, overall health, or well-being) in the 
treadmill-trained subjects after 12 or 24 weeks. In 
strength-trained subjects an improvement in well- 
being scores was seen after 12 weeks, but no 
improvement in other MOS parameters was seen. 
The control group had no change in MOS scores. In 
addition, no improvements in the MOS scores 
occurred in the second 12 weeks of treadmill training 
after strength training or in the combined treadmill 
and strength training program. 
Vitalog evaluation of  physical activity. On 
entry, 21 subjects from the three groups were 
monitored with the Vitalog. In these subjects data 
were continuously recorded for an average of 
11.2 _+ 2.4 hours. During the monitoring sessions 
all patients had an average of 13.3 _+ 7.9 bouts of 
activity per hour above their individual heart rate and 
activity level thresholds (Table V). The duration of 
these active periods was brief, lasting 10.9 _+ 4.9 
seconds. The number of active minutes per hour 
(derived from the number and duration o'feach active 
period) was also brief, averaging 2.3 -+ 1.6 minutes. 
When the total duration of activity was normalized to 
the total duration of the monitored session, only 
4.1% + 2.8% of the awake hours were spent in an 
active mode. 
After 12 weeks of treadmill training an increase of 
4.5 bouts of activity per hour (p < 0.05) occurred, 
with a trend to improve the number of active minutes 
per hour and percent time active. After 12 additional 
weeks of treadmill training the number of 
bouts/hour, active minutes, and percent ime active 
were all increased over baseline. In contrast, no 
improvements in Vitalog-assessed activity were seen 
in the strength-trained or control groups after 12 
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Table IV. Medical Outcomes Study Questionnaire scores on entry and change from baseline after 
12 and 24 weeks of exercise training 
Entry A Week 12 A Week 24 
Physical functioning score (%) 
TM 42 • 22 +24 (9 to 39)* TM +28 (9 to 47)* 
S 47 • 22 -2  ( -26  to 21) TM +10 ( -22  to 42) 
C 38 -+ 13 +15 ( -4  to 34) TM+ S +13 ( -8  to 35) 
Social functioning score (%) 
TM 54+ 27 +4 ( -28  to 36) TM +4 ( -25  to 34) 
S 60 -+ 30 -2  ( -26  to 21) TM -16  ( -48  to 16) 
C 53•  +10 ( -10  to 30) TM+S +10 ( -19  to 39) 
Role functioning score (%) 
TM 63 • 38 -3  ( -38  to 33) TM0 ( -24  to 24) 
S 69 + 55 0 ( -25  to 25) TM +5 ( -69  to 79) 
C 61 -+ 39 +4 ( -27  to 36) TM + S -3  ( -35  to 30) 
Overall health score (%) 
TM 7 + 26 +1 ( -10  to 11) TM +9 ( -7  to 25) 
S 57 • 18 +4 ( -7  to 14) TM +12 ( -4  to 27) 
C 53 • 29 -3  ( -24  to 18) TM + S +5 ( -11  to 22) 
Well-being score (%) 
TM 80 -+ 9 -2  ( -9  to 5) TM 0 ( -9  to 10) 
S 81 • 10 +9 (2 to 16)* TM +6 ( -4  to 15) 
C 76 + 22 +5 ( -8  to 17) TM + S -3  ( -9  to 4) 
TA/I, Treadmill-trained; S, strength-trained; C, control; TM + S, combined treadmill and strength training program. 
Data in parentheses under the week 12 and 24 columns represent 95% confidence intervals of these changes. Results are mean • SD. 
Ai Week 12 and 24 refers to change from baseline at each respective time point. 
*p < 0.05 week 12 or 24 versus entry value. 
Table V. Vitalog activity monitor esults on entry and change from baseline after 12 and 24 weeks 
of exercise training 
Entry A Week 12 A Week 24 
Bout length (sec) 
TM 13.3 _ 6.7 +2.5 ( -1 .3  to6.3) 
S 8.8 +- 0.8 +0.4 ( -0 .9  to 1.7) 
C 9.1 -+ 1.0 -0 .8  ( -1 .9 to  0.4) 
No. bouts/hr 
TM 10.7 • 4.1 +4.5 (0.5 to 8.5)* 
S 9.9 -+ 4.5 +0.7 ( -2 .2  to 3.6) 
C 20.0 + 11.0 +1.3 ( -4 .0  to 6.7) 
Active min/hr monitored 
TM 2.5 + 1.7 + 1.7 ( -0 .2  to 3.7) 
S 1.4 -+ 0.6 +0.2 ( -0 .1  to 0.5) 
C 2.8 -+ 1.8 +0.6 ( -0 .4  to 1.5) 
Percent ime active 
TM 4.1 • 2.8 +2.8 ( -0 .4  to 6.1) 
S 2.4 + 1.0 +0.3 ( -0 .2  to 0.8) 
C 5.3 -+ 3.3 +0.4 ( -1 .2  to 1.9) 
TM +2.4 ( -1 .1  to 5.9) 
TM +1.0 ( -1 .8  to 3.8) 
TM + S -1 .6  ( -4 .0  to 0.8) 
TM +8.2 (0.3 to 16.2)* 
TM +5.6 (0.8 to 10.4)* 
TM + S +8.6 ( -6 .1  to 23.3) 
TM + 1.6 (0.6 to 2.7)* 
TM +1.1 (0.6 to 1.6)* 
TM+ S +1.3 ( -1 .3  to 3.4) 
TM +2.8 (1.0 to 4.5)* 
TM + 1.8 (0.9 to 2.7)* 
TM + S +1.7 ( -2 .4  to 5.8) 
TA4, Treadmill-trained; S, strength-trained; C, control; TAd + S, combined treadmill and strength training program. 
Data in parentheses under the week 12 and 24 columns represent 95% confidence intervals of these changes. Results are mean + SD. 
A Week 12 and 24 refers to change from baseline at each respective time point. 
*p < 0.05 week 12 or 24 versus entry value. 
weeks. After 12 weeks of treadmill training after 
strength training, an increase in number of bouts per 
hour, active minutes, and percent time active 
(p < 0.05) was seen. The group that received 
combined strength and treadmill training had no 
improvement in Vitalog assessment of activity. 
DISCUSSION 
In  pat ients  w i th  d i sab l ing  c laud icat ion  caused by 
PAD,  12 weeks  o f  t readmi l l  t ra in ing  resu l ted in 
improvements  in funct iona l  status,  as ind icated  by  an 
increase in PAR-assessed  physical  activity,  MOS 
physical  funct ion ing ,  and  number  o f  bouts  o f  act iv ity 
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measured by the Vitalog. After an additional 12 
weeks of treadmill training, PAR and MOS improve- 
ments were maintained, and the WIQ-assessed ability 
to walk distances and claudication severity scores 
were also improved. After 24 weeks the Vitalog 
detected an increase in active minutes and percent 
time active in treadmill-trained subjects. These 
changes in physical functioning paralleled changes in 
treadmill-assessed peak walking time, which showed 
a progressive increase from 12 to 24 weeks as 
previously reported. 2~ Thus this comprehensive as- 
sessment demonstrated the benefits of supervised 
treadmill training. Not only was treadmill exercise 
performance improved, but physical functioning 
assessed by three different questionnaires and an 
activity monitor was also improved. These results 
support he recommendation of a 24-week treadmill 
training program for patients with disabling claudi- 
cation. 
A secondary aim of the study was to assess the 
benefits of different raining modalities. A muscle- 
strengthening program increased treadmill exercise 
performance but to a lesser extent han treadmill 
walking exercise. Strength training improved walk- 
ing speed and stair-climbing ability but no other 
aspects of physical functioning as assessed by the 
PAR, MOS, or Vitalog. Whether longer periods of 
strength training would be more effective was not 
answered by this study. Because strength training 
required intensive use of resources (one physical 
therapist for every two patients for each training 
session), a 24-week strength training program was 
not included in the original design. 
Combinations of training programs were also 
evaluated. Although only a small number of subjects 
completed the full 24-week program in which 
treadmill training followed strength training, these 
subjects had the expected increase in peak treadmill 
walking tim0 after the addition of 12 weeks of 
treadmill training. Consistent with this training 
effect, improvements in WIQ speed scores were 
maintained, and Vitalog-assessed activity also in- 
creased. In contrast, although the combined training 
program improved treadmill exercise performance, 
no improvement was seen in questionnaire or Vitalog 
measures of physical functioning. Clearly this study 
did not have sufficient subjects to definitively address 
the benefits of the combined training modalities. 
However, when compared with the significant 
changes in functional status and physical activity with 
treadmill training alone, further study of the com- 
bined training programs was not believed to be 
warranted. 
Functional status in patients with PAD com- 
pared with that of  historical control group. 
Treadmill training improved functional status in 
patients with clandication as compared with a non- 
treatment, PAD control group. However, whether 
treadmill-trained patients with PAD achieved the 
functional status of a nondiseased, age-matched 
control group was not assessed. To better evaluate the 
clinical effectiveness of treadmill training in patiehts 
with claudication, changes in selected questionnaire 
measures over the 24-week treadmill training pro- 
gram were compared with published values of 
healthy individuals in the same age range as patients 
in this study. 
The WIQ has been previously used to assess walk- 
ing impairment in patients with pAD.4-6 It has been 
used to evaluate changes in impairment after tread- 
mill training, peripheral bypass, and angioplasty? 6 
We considered that the WIQ, because it specifically 
measures aspects of walking impairment, would be 
the only questionnaire of the three that would reason- 
ably be correlated with treadmill walking time in the 
patient with PAD. In fact, modest correlations be- 
tween the WIQ questionnaire and peak treadmill 
walking time have previously been reported. ~ To fur- 
ther evaluate the relationship between WIQ and 
treadmill walking time, we have added together data 
from all patients with PAD who we have studied 
(n = 57). These patients were studied before and 
after an exercise program, before and after peripheral 
bypass, or before and after 12 weeks of no change in 
activity (control). We combined these groups be- 
cause (1) combining patients from several studies 
provided a larger sample size and a more broadly 
representative correlation, and (2) we reasoned that 
the questionnaire should be able to measure walking 
impairment regardless of the type of intervention 
used or lack of intervention toimprove walking abil- 
ity. We found several correlations among changes in 
aggregated WIQ scores, change in treadmill walking 
time, and change in time to onset of claudication. 
One such example isgiven in Fig. 1. 
In this study the mean WIQ distance score 
increased 71% after 24 weeks of treadmill training, 
reaching avalue of 82% _+ 24% (Fig. 2). However, 
the distance score did not attain the 'value of 
96% _+ 4% from an age-matched healthy control 
group from another study (Fig. 2). 21 It is interesting 
that four of nine patients achieved a distance score 
equal to that of a healthy control group after 24 weeks 
of training, whereas no patient had a "normal" score 
on ent ry .  
Similar to the findings with the WIQ, treadmill 
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training resulted in a 26% increase in estimated 
activity level to a mean value o f  195 -+ 51 MET 
hr /wk (Fig. 2). For comparison,  healthy older 
subjects from a previous populat ion study (the San 
Luis Valley Diabetes study) had a PAR score o f  
268 + 49 MET hr/wk, s No  patient with PAD 
achieved this expected mean value (Fig. 2). 
The MOS SF-20 questionnaire has been used in 
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large epidemiologic studies to evaluate functional 
status in a variety of diseased populations, ~ although 
not in patients with PAD. Exercise training resulted 
in a 62% increase in mean physical functioning scores 
in patients with claudication, achieving a value of 
68% _+ 16% (Fig. 3). However, this response to 
treatment did not equal the mean physical function- 
mg score of 86% in persons without chronic dis- 
eases, 12 although four of nine individual patients did 
achieve a score equal to that of the healthy control 
group. In contrast o the changes in physical func- 
tioning scores with training, questions about social 
function, rqle function, overall health, and well-being 
were not modified by treadmill training. Further, the 
well-being scores of the patients with PAD appeared 
to be similar to those of a healthy control group from 
a preGous study (Fig. 3). 12 Therefore the primary 
effects of treadmill training were all in the area of 
physical functioning, suggesting that improved walk- 
ing ability does not alter other domains of functional 
status. Because PAD is a disease in which the 
symptom of intermittent claudication limits walking 
ability, the benefits on the nonambulatory compo- 
nents of functional status might not be expected. 
Use of  an activity monitor. The Vitalog is a 
device that records objective information on activity 
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levels and heart rate, thus avoiding the potential bias 
of over- or underreporting physical activity in ques- 
tionnaire responses. 22 The instrument has been used 
in both healthy persons and in cardiovascular re- 
habilitation populations to evaluate habitual physi- 
cal activity, adherence to a training program, or 
both. ~4 In this study the heart rate and activity 
thresholds of the Vitalog were individually deter- 
mined at a treadmill walking speed of 2 mph, 0% 
grade (the first stage of the graded treadmill pro- 
tocol). Although the percent of time active mea- 
sured by the Vitalog increased 54% (to a mean value 
of 6.5% + 2.2%) after treadmill training, most 
bouts of activity were approximately 10 to 15 
seconds in duration both before and after training. 
These findings suggest that patients with claudi- 
cation tolerate only brief bursts of activity even after 
a training program. Exercise training apparently 
increases overall daily activity, primarily because 
patients perform an increased number of short- 
duration ambulatory activities. 
Conclusions. Patients with PAD who have in- 
termittent claudication have a very reduced tread- 
mill exercise performance that is associated with 
severe limitations in physical functioning and 
ambulatory activity in the community. A 24- 
week, supervised treadmill training program im- 
proves peak treadmill exercise performance, but this 
laboratory measure alone may not reflect any 
changes in functional status during daily activities. 
The results of this study confirm that the in- 
crease in treadmill exercise performance with tread- 
mill training is also reflected in improvements in 
physical functioning. Although all trained pa- 
tients did not achieve the expected level of function 
of healthy aged-matched persons, even small im- 
provements in function may have practical rel- 
evance. 
The use of a comprehensive battery of functional 
status measures and an activity monitor is an im- 
portant means to evaluate the benefits of therapy 
for patients with intermittent claudication. Because 
claudication is primarily a symptom that limits 
patients' functional capacity, future studies should 
incorporate functional measures of outcomes in the 
PAD population both before and after an inter- 
vention. 
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